Serviscope gets cash infusion
Independent service organization Serviscope announced this month that it is acquiring $10.5 million in new equity. The infusion should be the last round of private financing before the Wallingford, CT, ISO seeks public funds,according to Emile
Independent service organization Serviscope announced this month that it is acquiring $10.5 million in new equity. The infusion should be the last round of private financing before the Wallingford, CT, ISO seeks public funds,according to Emile Geisenheimer, Serviscope chairman and generalpartner of Nazem & Co., Serviscope's lead investor.
Serviscope has grown dramatically since it was founded in 1990.The company's cash requirements have grown as well, and as a resultServiscope has recently received several rounds of private equityfinancing.
The latest round will ensure the company's long-term stabilityand growth and will support Serviscope as it pursues an aggressiveexpansion strategy, Geisenheimer said. The financing also putsServiscope on a track to go public in the near future.
While Serviscope sorts out its financial picture, the companyis still searching for a new chief executive to replace DonaldSouthard, who left the company earlier this year (SCAN 4/6/94).
Clarius Mobile Health Unveils Anterior Knee Feature for Handheld Ultrasound
April 23rd 2025The T-Mode Anterior Knee feature reportedly offers a combination of automated segmentation and real-time conversion of grayscale ultrasound images into color-coded visuals that bolster understanding for novice ultrasound users.
The Reading Room Podcast: Current Perspectives on the Updated Appropriate Use Criteria for Brain PET
March 18th 2025In a new podcast, Satoshi Minoshima, M.D., Ph.D., and James Williams, Ph.D., share their insights on the recently updated appropriate use criteria for amyloid PET and tau PET in patients with mild cognitive impairment.
What is the Best Use of AI in CT Lung Cancer Screening?
April 18th 2025In comparison to radiologist assessment, the use of AI to pre-screen patients with low-dose CT lung cancer screening provided a 12 percent reduction in mean interpretation time with a slight increase in specificity and a slight decrease in the recall rate, according to new research.
